Literature DB >> 16634

The metabolism, distribution and elimination of chlorphentermine in man.

A H Beckett, P M Bélanger.   

Abstract

1 A gas-liquid chromatography procedure for the determination of chlorphentermine (I), N-hydroxychlorphentermine (II) and alpha,alpha-dimethyl-alpha-nitro-beta-(4-chlorophenyl)ethane (IV) in urine has been developed. Also methods are reported to determine conjugated II and the total N-oxidized metabolites of I, i.e. II, conjugated II, alpha,alpha-dimethyl-alpha-nitroso-beta-(4-chlorophenyl)ethane (III) and IV in urine. 2 The synthesis of alpha,alpha-dimethyl-alpha-nitroso-beta-(4-chlorophenyl)ethane (III) and its properties are reported. 3 The kinetics of urinary excretion of I and its metabolic products after the oral administration of I to a human subject on separate occasions have been studied. Under normal conditions of urinary pH, metabolism by N-oxidation was the main elimination route of I; acidifying the urine increased the urinary excretion of unchanged I at the expense of the N-oxidized products. 4 The importance of the N-oxidation metabolic route in the distribution of chlorphentermine (I) in man is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 16634      PMCID: PMC1429019          DOI: 10.1111/j.1365-2125.1977.tb00693.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  Chlophentermine-induced abnormalcytoplasmic inclusions in peripheral blood cells of rats and guinea pigs.

Authors:  R Lüllmann-Rauch
Journal:  Toxicol Appl Pharmacol       Date:  1975-04       Impact factor: 4.219

2.  The identification and analysis of the metabolic products of mephentermine.

Authors:  A H Beckett; P M Bélanger
Journal:  J Pharm Pharmacol       Date:  1975-12       Impact factor: 3.765

Review 3.  Drug-induced phospholipidosis.

Authors:  H Lüllmann; R Lüllmann-Rauch; O Wassermann
Journal:  Ger Med       Date:  1973

4.  Urinary excretion kinetics of amphetamine in man.

Authors:  A H Beckett; M Rowland
Journal:  J Pharm Pharmacol       Date:  1965-10       Impact factor: 3.765

5.  A note on spectrophotometric methods for the determination of norethynodrel and mestranol in tablets.

Authors:  R A Bastow
Journal:  J Pharm Pharmacol       Date:  1967-01       Impact factor: 3.765

6.  Evidence for an unusual distribution of chlorphentermine in vivo. An autoradiographic study in mice.

Authors:  K U Seiler; O Wassermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

7.  Drug-induced phospholipidosis. I. Lipid composition and chlorphentermine content of rat lung tissue and alveolar macrophages after chronic treatment.

Authors:  R Schmien; K U Seiler; O Wassermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

8.  The pharmacokinetics of phentermine and chlorphentermine in chronically treated rats.

Authors:  H Lüllmann; E Rossen; K U Seiler
Journal:  J Pharm Pharmacol       Date:  1973-03       Impact factor: 3.765

9.  Metabolism of chlorphentermine and phentermine in man to yield hydroxylamino, C-nitroso- and nitro-compounds.

Authors:  A H Beckett; P M Bélanger
Journal:  J Pharm Pharmacol       Date:  1974-03       Impact factor: 3.765

10.  Metabolic N-oxidation products of aliphatic amines as potential mediators in amine pharmacology.

Authors:  J W Gorrod; P Jenner
Journal:  Int J Clin Pharmacol Biopharm       Date:  1975-07
View more
  1 in total

Review 1.  Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices.

Authors:  Rafael de la Torre; Magí Farré; Mónica Navarro; Roberta Pacifici; Piergiorgio Zuccaro; Simona Pichini
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.